Search

everythinglearnresearchcommunity

for

Search:↓

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

The algorithm accurately identified alopecia in women of childbearing age using claims data.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

Clear definitions and strategies are needed to manage long-term COVID-19 symptoms effectively.

Upadacitinib may cause hair loss.

Treating primary cicatricial alopecia is difficult and requires evidence-based methods.

The PEEK cage reduced pain more than the dynamic cervical implant, but the implant allowed slightly better movement after surgery.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

DCP in isopropanol is better tolerated for treating alopecia areata.

Familial dyskeratotic comedones are a rare, inherited skin condition that is hard to treat but may improve slightly with topical retinoids and urea cream.

PC-associated alopecia has unique microscopic features.

ADSC injections improve hair density, thickness, and reduce inflammation in female pattern hair loss.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Poor air quality increases the risk of atopic dermatitis in Taiwan.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

IRS premature desquamation is not unique to CCCA and occurs in various scarring alopecias.

DACC-based dressings are more effective than silver-based ones for treating chronic wounds with antimicrobial resistance.

DPR can cause skin, hair, and nail issues, sometimes appearing later in life.

Acrodermatitis enteropathica is a rare inherited disorder causing skin issues, diarrhea, and hair loss.

Precocious puberty can signal familial adenomatous polyposis.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.